CART peptide inhibits locomotor activity induced by simultaneous stimulation of D1 and D2 receptors, but not by stimulation of individual dopamine receptors.
about
Decreased Caffeine-Induced Locomotor Activity via Microinjection of CART Peptide into the Nucleus Accumbens Is Linked to Inhibition of the pCaMKIIa-D3R InteractionCocaine-and-Amphetamine Regulated Transcript (CART) peptide attenuates dopamine- and cocaine-mediated locomotor activity in both male and female rats: lack of sex differences.The Melanin-Concentrating Hormone as an Integrative Peptide Driving Motivated BehaviorsPredominant D1 Receptors Involvement in the Over-expression of CART Peptides after Repeated Cocaine Administration.Intra-accumbal administration of shRNAs against CART peptides cause increases in body weight and cocaine-induced locomotor activity in rats.Neurotransmitter CART as a New Therapeutic Candidate for Parkinson's DiseaseThe inhibition of cocaine-induced locomotor activity by CART 55-102 is lost after repeated cocaine administration.Compulsive methamphetamine taking in the presence of punishment is associated with increased oxytocin expression in the nucleus accumbens of ratsInjection of Cocaine-Amphetamine Regulated Transcript (CART) peptide into the nucleus accumbens does not inhibit caffeine-induced locomotor activity: Implications for CART peptide mechanism.CART Peptides and Drugs of Abuse: A Review of Recent Progress.CART peptide in the nucleus accumbens regulates psychostimulants: Correlations between psychostimulant and CART peptide effects.Cocaine- and Amphetamine-Regulated Transcript (CART) Peptide Plays Critical Role in Psychostimulant-Induced Depression
P2860
Q27334685-7980BD84-682F-41EE-89D9-0172AD8E316DQ33622626-C2B87ACC-47E6-4AC1-9E52-3095CFE8C27DQ33734660-F9F52FA6-DB95-4F0E-B2C7-9B6A34699D4DQ35127508-F009DB62-DBDC-4BD2-8079-D706F37AC3A1Q36367076-7E33BEE6-6E2B-4A82-9FB2-A0BC2F9A65EAQ36720922-0FBD57AE-FCB5-421E-89E4-5EF541988F3DQ37513792-D3F2BFF5-3E05-4086-B215-92CA32F46AFBQ41484322-28504EA9-CDD1-4516-A9DA-1B2B24DD5E19Q42382069-3B36C597-E6C4-4629-B9E6-1AC396967C08Q47096614-2F4A4B12-9EF5-4334-A040-D887581FA515Q47328693-02B742B9-C36F-4B03-85D5-02C2E1A4544CQ58775608-A6930928-06E2-4BD2-9491-BDE528D2EB51
P2860
CART peptide inhibits locomotor activity induced by simultaneous stimulation of D1 and D2 receptors, but not by stimulation of individual dopamine receptors.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
CART peptide inhibits locomoto ...... individual dopamine receptors.
@ast
CART peptide inhibits locomoto ...... individual dopamine receptors.
@en
CART peptide inhibits locomoto ...... individual dopamine receptors.
@nl
type
label
CART peptide inhibits locomoto ...... individual dopamine receptors.
@ast
CART peptide inhibits locomoto ...... individual dopamine receptors.
@en
CART peptide inhibits locomoto ...... individual dopamine receptors.
@nl
prefLabel
CART peptide inhibits locomoto ...... individual dopamine receptors.
@ast
CART peptide inhibits locomoto ...... individual dopamine receptors.
@en
CART peptide inhibits locomoto ...... individual dopamine receptors.
@nl
P2093
P2860
P356
P1433
P1476
CART peptide inhibits locomoto ...... individual dopamine receptors.
@en
P2093
Mark C Moffett
Michael J Kuhar
P2860
P356
10.1002/SYN.20815
P577
2011-01-01T00:00:00Z